Celleris Clinical Research Sp. z o.o. Company Profile - Poland | Contacts & Key Executives

Celleris Clinical Research Sp. z o.o. (Poland)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Secondary Activities: Administrative Management and General Management Consulting Services | Scientific Research and Development Services | Research and Development in Biotechnology (except Nanobiotechnology) | All Other Professional, Scientific, and Technical Services | All Other Miscellaneous Schools and Instruction | Educational Support Services | Ambulatory Health Care Services | All Other Miscellaneous Ambulatory Health Care Services | General Medical and Surgical Hospitals

Full name: Celleris Clinical Research Sp. z o.o.

Profile Updated: January 08, 2025

Celleris Clinical Research Sp. z o.o. is based in Poland, with the head office in Warsaw. It operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) sector. The enterprise was incorporated on January 03, 2025.

Headquarters
Ul. Zurominska 15/30
Warsaw; Mazowieckie; Postal Code: 03-341

Contact Details: Purchase the Celleris Clinical Research Sp. z o.o. report to view the information.

Website: http:// 5. adres do doręczeń elektronicznych wpisany do bazy adresów elektronicznych

Basic Information

Outstanding Shares:

Purchase the Celleris Clinical Research Sp. z o.o. report to view the information.

Registered Capital:

Purchase the Celleris Clinical Research Sp. z o.o. report to view the information.

Incorporation Date:

January 03, 2025

Key Executives

Purchase this report to view the information.

President

Ownership Details

Purchase this report to view the information.

50%

Purchase this report to view the information.

50%

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service